Mateti, U. V., Nagappa, A. N., & Balkrishnan, R. (2014). Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India. Medknow Publications & Media Pvt Ltd.
Citación estilo ChicagoMateti, Uday Venkat, Anantha Naik Nagappa, y Rajesh Balkrishnan. Why Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Not Prescribed in the Management of Hypertension Among Hemodialysis Patients in India. Medknow Publications & Media Pvt Ltd, 2014.
Cita MLAMateti, Uday Venkat, Anantha Naik Nagappa, y Rajesh Balkrishnan. Why Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Not Prescribed in the Management of Hypertension Among Hemodialysis Patients in India. Medknow Publications & Media Pvt Ltd, 2014.